Literature DB >> 97364

Experimental infection of chimpanzees with the Norwalk agent of epidemic viral gastroenteritis.

R G Wyatt, H B Greenberg, D W Dalgard, W P Allen, D L Sly, T S Thornhill, R M Chanock, A Z Kapikian.   

Abstract

A fecal filtrate of human origin containing the Norwalk agent of epidemic viral gastroenteritis was administered by stomach tube to chimpanzees in an attempt to induce diarrheal disease. Significant postchallenge serum antibody rises against Norwalk viral antigens were demonstrated in all animals using the techniques of immune electron microscopy and radioimmunoassay. In addition, viral antigens were detected in feces from five of nine animals using radioimmunoassay. Clinical illness characterized by diarrhea and/or vomiting did not occur. Infection was transmitted subsequently by feeding four additional chimpanzees a fecal filtrate prepared from one of the previously infected animals. Development of an antibody response in four animals and detection of viral antigen in two animals that received this passage filtrate indicated that viral replication had occurred in the absence of clinical illness. The availability of the chimpanzee as an experimental animal host susceptible to infection with the Norwalk agent should facilitate the study of epidemic viral gastroenteritis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 97364     DOI: 10.1002/jmv.1890020203

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  29 in total

1.  Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens.

Authors:  Anne M Hutson; Robert L Atmar; Donald M Marcus; Mary K Estes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Interaction of recombinant norwalk virus particles with the 105-kilodalton cellular binding protein, a candidate receptor molecule for virus attachment.

Authors:  M Tamura; K Natori; M Kobayashi; T Miyamura; N Takeda
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein.

Authors:  X Jiang; M Wang; D Y Graham; M K Estes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane.

Authors:  Masaru Tamura; Katsuro Natori; Masahiko Kobayashi; Tatsuo Miyamura; Naokazu Takeda
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

5.  Detection of norovirus-, sapovirus- and rhesus enteric calicivirus-specific antibodies in captive juvenile macaques.

Authors:  Tibor Farkas; Jason Dufour; Xi Jiang; Karol Sestak
Journal:  J Gen Virol       Date:  2009-11-04       Impact factor: 3.891

Review 6.  Advances in norovirus biology.

Authors:  Stephanie M Karst; Christiane E Wobus; Ian G Goodfellow; Kim Y Green; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

Review 7.  Vaccine against norovirus.

Authors:  Ming Tan; Xi Jiang
Journal:  Hum Vaccin Immunother       Date:  2014-05-05       Impact factor: 3.452

8.  Characterization of a rhesus monkey calicivirus representing a new genus of Caliciviridae.

Authors:  Tibor Farkas; Karol Sestak; Chao Wei; Xi Jiang
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Heat shock protein 70 enhances mucosal immunity against human norovirus when coexpressed from a vesicular stomatitis virus vector.

Authors:  Yuanmei Ma; Yue Duan; Yongwei Wei; Xueya Liang; Stefan Niewiesk; Michael Oglesbee; Jianrong Li
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

10.  Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations.

Authors:  K Y Green; J F Lew; X Jiang; A Z Kapikian; M K Estes
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.